引用本文:
【打印本页】   【下载PDF全文】   查看/发表评论  下载PDF阅读器  关闭
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1989次   下载 1246 本文二维码信息
码上扫一扫!
分享到: 微信 更多
伊维菌素在吉富罗非鱼体内的药物动力学
李世凯1,2, 江 敏1, 吴 昊,等1
1.上海海洋大学 水产与生命学院;2.贵州省水产研究所
摘要:
【目的】研究伊维菌素(IVM)在吉富罗非鱼体内的药物动力学,为其在罗非鱼养殖中的合理应用提供依据。【方法】将吉富罗非鱼按1 mg/kg的给药剂量肌肉注射IVM,采用高效液相色谱法于给药后不同时间点对各组织进行采样检测,通过DAS 3.0药物代谢动力学软件分析IVM在吉富罗非鱼体内的药代动力学参数。【结果】在肌肉注射给药方式下,吉富罗非鱼血液中IVM质量浓度C随时间t的药物动力学模型符合一级吸收二室开放模型,其药物动力学方程为:C血液=0.215e-0.016(t-0.22)+0.198e0-0.413e-1.294(t-0.22)。肌肉注射给药后,IVM在血液及肌肉、肾脏、精巢和肝脏的峰含量(Cmax)分别为0.424 mg/L及0.757,0.618,0.571,1.514 mg/kg;达峰时间(Tmax)分别为8,24,8,16和24 h;AUC(0-∞)分别为506.134,89.445,143.794,99.824和507.977 mg/(L·h);MRT(0-∞)分别为1 810.979,176.789,194.868,312.487和259.84 h;t1/2z分别为1 208.304,155.129,67.049,231.330和165.918 h;各组织的药物代谢动力学方程分别为:C肌肉=4.219e-0.037t+0.217e-0.004t-4.436e-0.049tC肾脏=0.001e-0.005t+0.713e-0.004t-0.714e-0.031tC精巢=3.479e-0.096t+0.25e-0.003t-3.729e-0.119tC肝脏=1.764(e-0.004t-e-0.132t)。【结论】IVM在吉富罗非鱼体内的药物动力学特征表现为:吸收快、分布广、消除缓慢。因此初步确定在水温(26±1) ℃下肌肉注射1 mg/kg IVM,其休药期为25 d。
关键词:  伊维菌素  吉富罗非鱼  药物动力学  高效液相色谱  休药期
DOI:
分类号:
基金项目:欧盟科研架构计划项目(EU-FP7-SEAT222889);上海市教委重点学科建设项目(J50701);上海市高校知识服务平台项目(ZF1206)
Pharmacokinetics of ivermectin in GIFT tilapia (Oreochromis niloticus)
LI Shikai,JIANG Min,WU Hao,et al
Abstract:
【Objective】This paper studied pharmacokinetics of ivermectin in GIFT tilapia (Oreochromis niloticus) to provide basis for its rational application.【Method】Ivermectin was given to GIFT tilapia (Oreochromis niloticus) through a single intramuscular administration at dose of 1 mg/kg,then tilapia tissues samples were taken at different time points and analyzed by high-performance liquid chromatography(HPLC) before the pharmacokinetics parameters were calculated using DAS 3.0 software.【Result】With intramuscular administration,the best pharmacokinetic model of blood was two-compartmental open model with first-order absorption:Cblood=0.215e-0.016(t-0.22)+0.198e0-0.413e-1.294(t-0.22).After administration,non-compartmental pharmacokinetic parameters in blood,muscle,kidney,spermary and liver were:Cmax 0.424 mg/L and 0.757,0.618,0.571,1.514 mg/kg,Tmax 8,24,8,16 and 24 h,AUC(0-∞) 506.134,89.445,143.794,99.824 and 507.977 mg/(L·h),MRT(0-∞) 1 810.979,176.789,194.868,312.487 and 259.84 h,and t1/2z 1 208.304,155.129,67.049,231.330 and 165.918 h,respectively.The pharmacokinetics equations in muscle,kidney,spermary and liver were Cmuscle=4.219e-0.037t+0.217e-0.004t-4.436e-0.049t,Ckidney=0.001e-0.005t+0.713e-0.004t-0.714e-0.031t,Cspermary=3.479e-0.096t+0.25e-0.003t-3.729e-0.119t,and Cliver=1.764(e-0.004t-e-0.132t).【Conclusion】The pharmacokinetic characteristics of IVM in GIFT tilapia were fast absorption,wide distribution and slow elimination. When water temperature was (26±1) ℃ and intramuscular administration dose was 1 mg/kg,drug withdrawal time in muscle was 25 d.
Key words:  ivermectin  GIFT tilapia (Oreochromis niloticus)  pharmacokinetics  high-performance liquid chromatography(HPLC)  withdraw period